The Human Factor in MedTech Design with Dylan Horvath | Ep. 20 - Full Transcript | The Med Device Cyber Podcast
Read the complete, searchable transcript of Episode 37 of The Med Device Cyber Podcast - expert conversations on medical device cybersecurity, FDA premarket and postmarket guidance, SBOM management, threat modeling, and penetration testing.
Prefer the listening experience? Open the episode page for the synopsis, key takeaways, topics, and Apple / YouTube listen links.
Episode summary
In this episode of The Med Device Cyber Podcast, host Christian Espinosa is joined by Dylan Horvath, the CEO and founder of Cortex Design, a firm specializing in medical device design and development. The conversation centers on the critical role of human-centered design and human factors engineering within the medical device industry. Dylan Horvath brings his extensive experience, having founded Cortex in 1999 and gradually shifting the company's focus to the highly regulated and impactful MedTech space. He discusses the common challenges and misconceptions surrounding industrial design in North America, particularly within medical technology, where it's often narrowly perceived as mere aesthetics or "look and feel." Horvath argues that the medical device industry has historically been a "laggard" in integrating design as a core component of the development process. He emphasizes a more holistic, cohesive philosophy where industrial design and human factors engineering are intertwined. A central theme is the distinction between a device being "safe and effective"—the baseline for regulatory approval—and being "commercially successful." Commercial success, he posits, hinges on market adoption, which is driven by creating products that people not only need but also want and find intuitive to use. This requires a deep understanding of the user and their environment, especially in high-risk settings like operating rooms. The discussion delves into the practicalities of the design process. Horvath stresses the necessity of integrating human factors engineering from the very beginning, starting with user requirements, indications for use, and intended use statements. He expands the concept of the "user" to include all stakeholders in the device's ecosystem, including the purchasers (who may be different from the end-users) and those who decide on reimbursement. Overlooking any of these stakeholders can lead to market failure. This "shift-left" approach, as the host Christian Espinosa notes, is analogous to best practices in cybersecurity, where addressing issues early is far less costly and more effective than trying to bolt on solutions at the end of the development cycle. Making design or hardware changes late in the process, especially after regulatory testing, can be prohibitively expensive and cause significant delays.
Key takeaways from this episode
- Human-centered design must be integrated from the very beginning of the medical device development process, not treated as an afterthought.
- A medical device being "safe and effective" for regulatory approval does not guarantee its commercial success; market adoption depends on usability and user desirability.
- The medical device industry has historically been slow to adopt design as a core part of product development, often limiting it to superficial aesthetics.
- Effective design considers all stakeholders, including the end-user (e.g., surgeon), the purchaser (e.g., hospital administration), and those who determine reimbursement.
- Changing design, hardware, or firmware late in the development process is extremely expensive and can cause major delays, highlighting the need for early planning.
- Industrial design and human factors engineering should be viewed as a cohesive whole, working together to create a seamless and effective user experience.
- To achieve market success, it's crucial to design a product that people will like and understand how to use, not just a product that the design team personally likes.